Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: Stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry

Stroke

Volumn 42, Issue 8, 2011, Pages 2196-2200

  Nezu, Tomohisa ^a   Koga, Masatoshi ^a   Nakagawara, Jyoji ^b   Shiokawa, Yoshiaki ^c   Yamagami, Hiroshi ^d   Furui, Eisuke ^e   Kimura, Kazumi ^f   Hasegawa, Yasuhiro ^g   Okada, Yasushi ^h   Okuda, Satoshi ⁱ   Kario, Kazuomi ^j   Naganuma, Masaki ^a   Maeda, Koichiro ^a   Minematsu, Kazuo ^a   Toyoda, Kazunori ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b Nakamura Memorial Hospital   (Japan)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^e KOHNAN HOSPITAL   (Japan)

^f KAWASAKI MEDICAL SCHOOL   (Japan)

^g ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

ⁱ NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^j JICHI MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

acute stroke; diffusion weighted MRI; early ischemic sign; thrombolysis

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANKIN SCALE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX RATIO; STROKE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79961207089     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.614404     Document Type: Article

References (26)

1. Moulin T, Cattin F, Crepin-Leblond T, Tatu L, Chavot D, Piotin M, et al. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology. 1996;47:366-375. (Pubitemid 26324029)
2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
3. Silver B, Demaerschalk B, Merino JG, Wong E, Tamayo A, Devasenapathy A, et al. Improved outcomes in stroke thrombolysis with pre-specified imaging criteria. Can J Neurol Sci. 2001;28:113-119. (Pubitemid 32521798)
4. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711. (Pubitemid 46691097)
5. Norris JW, Buchan A, Cote R, Hachinski V, Phillips SJ, Shuaib A, et al. Canadian guidelines for intravenous thrombolytic treatment in acute stroke. A consensus statement of the Canadian Stroke Consortium. Can J Neurol Sci. 1998;25:257-259. (Pubitemid 28368805)
6. The European Stroke Organisation Executive Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
7. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670-1674. (Pubitemid 30248478)
8. Wardlaw JM, Mielke O. Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment-systematic review. Radiology. 2005;235:444-453. (Pubitemid 40571081)
9. Kang DW, Chalela JA, Dunn W, Warach S. MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke. 2005;36:1939-1943. (Pubitemid 41266531)
10. Schellinger PD, Thomalla G, Fiehler J, Kohrmann M, Molina CA, Neumann-Haefelin T, et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke. 2007;38:2640-2645. (Pubitemid 47493997)
11. Singer OC, Kurre W, Humpich MC, Lorenz MW, Kastrup A, Liebeskind DS, et al. Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWI-ASPECTS. Stroke. 2009;40:2743-2748.
12. Kimura K, Iguchi Y, Shibazaki K, Terasawa Y, Inoue T, Uemura J, et al. Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke. Stroke. 2008;39:2388-2391.
13. Nakashima T, Toyoda K, Koga M, Matsuoka H, Nagatsuka K, Takada T, et al. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke. Int J Stroke. 2009;4:425-431.
14. Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, et al. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry. Neurology. 2010;75:555-561.
15. Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry. 2005;76:1528-1533. (Pubitemid 41531700)
16. Morita N, Harada M, Uno M, Matsubara S, Nagahiro S, Nishitani H. Evaluation of initial diffusion-weighted image findings in acute stroke patients using a semiquantitative score. Magn Reson Med Sci. 2009;8:47-53.
17. Toyoda K, Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, et al. Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients. General outcomes and prognostic factors from the SAMURAI Register. Stroke. 2009;40:3591-3595.
18. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
19. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, et al. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke. 2006;37:1810-1815. (Pubitemid 44297734)
20. Shinohara Y, Yamaguchi T. Outline of the Japanese guidelines for the management of stroke 2004 and subsequent revision. Int J Stroke. 2008; 3:55-62. (Pubitemid 351228146)
21. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41. (Pubitemid 23014379)
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
23. Kosior RK, Lauzon ML, Steffenhagen N, Kosior JC, Demchuk A, Frayne R. Atlas-based topographical scoring for magnetic resonance imaging of acute stroke. Stroke. 2010;41:455-460.
24. Kim EY, Ryoo JW, Roh HG, Lee KH, Kim SS, Song IC, et al. Reversed discrepancy between CT and diffusion-weighted MR imaging in acute ischemic stroke. AJNR Am J Neuroradiol. 2006;27:1990-1995. (Pubitemid 44556523)
25. Saur D, Kucinski T, Grzyska U, Eckert B, Eggers C, Niesen W, et al. Sensitivity and interrater agreement of CT and diffusion-weighted MR imaging in hyperacute stroke. AJNR Am J Neuroradiol. 2003;24:878-885. (Pubitemid 36617418)
26. Barber PA, Darby DG, Desmond PM, Gerraty RP, Yang Q, Li T, et al. Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. Stroke. 1999;30:2059-2065. (Pubitemid 29473249)